Stephen Dilly, new Codexis president and CEO
Shortly after selling Sierra to GSK, Stephen Dilly heads to enzyme engineer Codexis as new CEO
On Feb. 22, Stephen Dilly had no clear ambitions of selling Sierra Oncology to GSK. But that quickly changed over the subsequent weeks, and …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
